Thermo Fisher revenue up 33%
Testing company reports a stellar Q2 after acquiring Life Technologies.
July 24, 2014
![Thermo Fisher revenue up 33% Thermo Fisher revenue up 33%](https://eu-images.contentstack.com/v3/assets/blt09e5e63517a16184/blt7050441b7f733c79/64e897a64645ad5d21c3bde4/thermo-fisher-scientific.png?width=1280&auto=webp&quality=95&format=jpg&disable=upscale)
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, reported its financial results for the second quarter ended June 28, 2014, the first full quarter including the Life Technologies acquisition and excluding the related divestitures.
Second quarter highlights:
Grew adjusted earnings per share (EPS) by 30 percent to $1.72
Increased revenue by 33 percent to $4.32 billion
Expanded adjusted operating margin by 210 basis points to 21.4 percent
Generated free cash flow of $823 million
Launched new Thermo Scientific consumables, instruments and software at the American Society of Mass Spectrometry conference to strengthen industry leadership, highlighted by the new Q Exactive HF system and the new TSQ 8000 Evo triple quad.
Expanded capabilities at Centers of Excellence in Lithuania and Germany to support growth of molecular biology products for life sciences and diagnostics, and to meet demand for mass spectrometry systems used in research and applied markets.
Adjusted EPS, adjusted operating income, adjusted operating margin and free cash flow are non-GAAP measures that exclude certain items detailed later in this press release under the heading “Use of Non-GAAP Financial Measures.”